Reviewed by Alvin Philipose, DC, ICCP. Educational content only. Ozone therapy in all the forms described below is considered investigational in the United States and is not approved by the FDA to diagnose, treat, cure, or prevent any disease.
The short answer
EBOO, 10-pass, and standard IV ozone (major autohemotherapy) are three different ways of exposing blood to medical ozone outside the body and returning it. They differ in how much blood is processed, whether the blood is filtered, how long the session takes, and how much equipment and monitoring is involved.
They have not been compared against each other in a head-to-head clinical trial. Any page that tells you one of them is definitively better than the others is telling you something the published evidence does not currently support. That includes this page, if we ever say it to you.
What each procedure actually is
Major autohemotherapy (standard IV ozone)
A quantity of blood is drawn into a sterile container, mixed with an ozone-oxygen gas mixture, and returned through the same line. It is a single exposure. It is the oldest and simplest of the three, uses the least equipment, and takes the least time.
10-pass ozone therapy
The same basic idea, repeated. Blood is drawn, ozonated under positive pressure, and returned, and that cycle is performed multiple times in one sitting, conventionally up to ten. Each pass handles a similar volume to a standard session, so the cumulative volume processed is substantially higher. It requires a pressure-capable machine and takes considerably longer.
EBOO (extracorporeal blood oxygenation and ozonation)
Rather than cycling batches, EBOO runs a continuous circuit: blood leaves through one line, passes through a gas-exchange membrane and a filter, and returns through a second line. Because it is continuous rather than batched, the total volume that passes through the circuit during a session is larger than either of the other two. The filtration step is what distinguishes EBOO mechanically from the other two protocols; the others do not filter.
Side by side
| Standard IV ozone (MAH) | 10-pass | EBOO | |
|---|---|---|---|
| Method | Single batch | Repeated batches | Continuous circuit |
| Filtration | No | No | Yes |
| Venous access | One line | One line | Two lines |
| Relative session length | Shortest | Longest | Intermediate to long |
| Equipment and monitoring | Least | Moderate | Most |
| Anticoagulation | Required | Required | Required, central to the procedure |
| Regulatory status in the US | Investigational | Investigational | Investigational |
Specific volumes, gas concentrations, and session times vary by device, protocol, and the person being treated. We have deliberately not published numbers here, because ranges quoted on marketing pages are frequently device-specific and are often reproduced inaccurately from one site to the next.
Is more ozone better?
This is the question the comparison usually turns on, and it deserves a more careful answer than it normally gets.
The argument for the higher-volume protocols is straightforward: more blood is exposed to ozone, therefore the biological signal is larger. The difficulty is that ozone is generally described in the ozone-therapy literature as a hormetic agent, meaning the response is dose-dependent in a non-linear way and there is a window rather than a slope. Work by Viebahn-Haensler and colleagues on therapeutic windows, and dosing guidance from practitioners such as Lamberto Re, both describe an intended range rather than an ever-increasing benefit. Under that model, exceeding the window is not a stronger version of the same effect.
What follows from this is narrow but real: the fact that one protocol processes more blood than another is a statement about the procedure, not a demonstration of better outcomes. Volume comparisons are frequently presented as though they settle the clinical question. They do not.
What the evidence does and does not establish
- Not established: that any one of these three protocols produces better clinical outcomes than the others. No head-to-head trial has been published.
- Not established: that any of them treats, cures, or prevents a specific disease. None is FDA-approved for any indication.
- Reasonably documented: the procedural mechanics above, which are device and protocol facts rather than outcome claims.
- Reported in safety surveys: adverse event rates for intravenous ozone administration collected by the International Scientific Committee of Ozone Therapy. Survey data of this kind reflects what practitioners report and is not equivalent to trial safety data.
Anyone comparing these three should be reading the distinction between those categories, not the adjectives around them.
Risks worth understanding before you choose anything
All three involve venous access, anticoagulation, and handling of blood outside the body, so all three carry the risks associated with those things, including bleeding risk, line-related complications, and infection risk. The more complex the circuit, the more that has to be monitored during the session. Ozone must never be administered by direct inhalation.
These procedures are not appropriate for everyone. Bleeding disorders, anticoagulant medication, G6PD deficiency, pregnancy, uncontrolled cardiovascular disease, and recent surgery are all reasons a clinician may decline to proceed or refer you elsewhere. That assessment happens before anything is scheduled.
How the decision gets made at Venturis Clinic
We do not start from the protocol. We start from your history, what you have already tried, what testing exists, and whether an ozone-based approach is a reasonable fit at all. Some people who ask about EBOO are better served by something else, and some are not candidates for extracorporeal procedures for reasons that have nothing to do with which protocol is fashionable.
Venturis Clinic performs EBOO and other ozone-based protocols in Oklahoma City. Which one is appropriate, or whether any of them is, is a clinical determination made after evaluation. It is not something we can answer from a web page, and we would be suspicious of anyone who tells you otherwise before meeting you.
Read more about EBOO ozone therapy at our Oklahoma City clinic, or start with a free 15-minute discovery call to find out whether this is worth your time.
Frequently asked questions
Is EBOO better than 10-pass ozone therapy?
There is no published head-to-head trial establishing that it is. They differ in method, in whether the blood is filtered, and in session length. Those are procedural differences, not proof of superior results.
What is the main difference between EBOO and IV ozone?
Standard IV ozone treats a single batch of blood and returns it. EBOO runs a continuous circuit through a gas-exchange membrane and a filter, using two venous lines instead of one.
How many sessions are typical?
Protocols vary widely and are set individually. Any number quoted before an evaluation is a marketing figure, not a treatment plan.
Is ozone therapy FDA-approved?
No. Ozone therapy is not approved by the FDA for the treatment of any disease, and all three protocols described here are investigational in the United States.
What does it cost?
Cost depends on what is clinically appropriate, which is determined after evaluation. We do not quote treatment pricing before a clinician has determined whether a case can be taken.
Who should not have these procedures?
People with bleeding disorders, those on anticoagulants, people with G6PD deficiency, people who are pregnant, and people with uncontrolled cardiovascular disease are among those for whom these procedures may be inappropriate. This is assessed individually.
Alvin Philipose, DC, ICCP
Ozone therapy, EBOO (extracorporeal blood oxygenation and ozonation), and related intravenous protocols are not approved by the U.S. Food and Drug Administration for any condition or disease. These therapies are considered investigational and are not guaranteed to diagnose, treat, cure, or prevent any specific medical condition. Nothing on this page is medical advice and nothing here creates a doctor-patient relationship. Individual responses vary and cannot be predicted. Please consult your own physician before beginning any treatment.